|
| Issue Date | Title | Author(s) |
| 4-Dec-2014 | Beclin 1 restrains tumorigenesis through Mcl-1 destabilization in an autophagy-independent reciprocal manner | Elgendy, Mohamed; Ciro, Marco; Abdel-Aziz, Amal Kamal ; Belmonte, Giuseppe; Dal Zuffo, Roberto; Mercurio, Ciro; Miracco, Clelia; Lanfrancone, Luisa; Foiani, Marco; Minucci, Saverio |
| 2019 | Chemotherapy and cognition: comprehensive review on doxorubicin-induced chemobrain | El-Agamy, Sara Emad; Abdel-Aziz, Amal Kamal ; Esmat, Ahmed; Azab, Samar S |
| 25-Jun-2014 | Chloroquine synergizes sunitinib cytotoxicity via modulating autophagic, apoptotic and angiogenic machineries | Abdel-Aziz, Amal Kamal ; Shouman, Samia; El-Demerdash, Ebtehal; Elgendy, Mohamed; Abdel-Naim, Ashraf B |
| 2022 | Co-targeting leukemia-initiating cells and leukemia bulk leads to disease eradication | Moretti, Simona; Abdel-Aziz, Amal Kamal ; Ceccacci, Elena; Pallavicini, Isabella; Santoro, Fabio; de Thé, Hugues; Minucci, Saverio |
| 2018 | Comparative study of anti-VEGF Ranibizumab and Interleukin-6 receptor antagonist Tocilizumab in Adjuvant-induced Arthritis | Abdel-Maged, Amany El-Shahawy; Gad, Amany M; Abdel-Aziz, Amal Kamal ; Azab, Samar S; Aboulwafa, Mohammad M |
| 8-Jul-2019 | Comparing apples with oranges: Studying LSD1 inhibitors in cellular assays | Abdel-Aziz, Amal Kamal ; Minucci, Saverio |
| Jan-2021 | Dendritic cell vaccine immunotherapy; the beginning of the end of cancer and COVID-19. A hypothesis | Saadeldin, Mona Kamal; Abdel-Aziz, Amal Kamal ; Abdellatif, Ahmed |
| Dec-2022 | Discovery of EMD37, a 1,2,4-oxadiazole derivative, as a novel endoplasmic reticulum stress inducer with potent anticancer activity | Abdel-Aziz, Amal Kamal ; Khaled A M Abouzid ; Minucci, Saverio; Dokla, Eman |
| 15-Apr-2016 | Discovery of Potent VEGFR-2 Inhibitors based on Furopyrimidine and Thienopyrimidne Scaffolds as Cancer Targeting Agents | Aziz, Marwa A; Serya, Rabah A T; Lasheen, Deena S. ; Abdel-Aziz, Amal Kamal ; Mansour, Ahmed M; Ahmed Esmat ; Singab A. ; Khaled A M Abouzid |
| 2017 | Dual modulation of MCL-1 and mTOR determines the response to sunitinib | Elgendy, Mohamed; Abdel-Aziz, Amal Kamal ; Renne, Salvatore Lorenzo; Bornaghi, Viviana; Procopio, Giuseppe; Colecchia, Maurizio; Kanesvaran, Ravindran; Toh, Chee Keong; Bossi, Daniela; Pallavicini, Isabella; Perez-Gracia, Jose Luis; Lozano, Maria Dolores; Giandomenico, Valeria; Mercurio, Ciro; Lanfrancone, Luisa; Fazio, Nicola; Nole, Franco; Teh, Bin Tean; Renne, Giuseppe; Minucci, Saverio |
| 2017 | From Resistance to Sensitivity: Insights and Implications of Biphasic Modulation of Autophagy by Sunitinib | Abdel-Aziz, Amal Kamal ; Abdel-Naim, Ashraf B; Shouman, Samia; Minucci, Saverio; Elgendy, Mohamed |
| Jan-2019 | Mechanistic approach of the inhibitory effect of chrysin on inflammatory and apoptotic events implicated in radiation-induced premature ovarian failure: Emphasis on TGF-β/MAPKs signaling pathway | Mantawy, Eman M; Said, Riham S; Abdel-Aziz, Amal Kamal |
| Jan-2015 | Modulation of imatinib cytotoxicity by selenite in HCT116 colorectal cancer cells | Abdel-Aziz, Amal Kamal ; Azab, Samar Saad Eldeen; Youssef, Samar Samir; El-Sayed, Abeer Mostafa; El-Demerdash, Ebtehal; Shouman, Samia |
| 2022 | Preclinical activity of fluvastatin-loaded self-nanoemulsifying delivery system against breast cancer models: Emphasis on apoptosis | Elimam, Hanan; Hussein, Jihan; Abdel-Latif, Yasmin; Abdel-Aziz, Amal Kamal ; El-Say, Khalid M |
| 2019 | Preclinical models of breast cancer: Two-way shuttles for immune checkpoint inhibitors from and to patient bedside | Abdel-Aziz, Amal Kamal ; Saadeldin, Mona Kamal; D'Amico, Paolo; Orecchioni, Stefania; Bertolini, Francesco; Curigliano, Giuseppe; Minucci, Saverio |
| 21-Jun-2015 | Rational design, synthesis and molecular modeling studies of novel anti-oncological alkaloids against melanoma | Girgis, Adel S; Panda, Siva S; Srour, Aladdin M; Farag, Hanaa; Ismail, Nasser S M; Elgendy, Mohamed; Abdel-Aziz, Amal Kamal ; Katritzky, Alan R |
| 2018 | Serum sclerostin and irisin as predictive markers for atherosclerosis in Egyptian type II diabetic female patients: A case control study | Saadeldin, Mona Kamal; Elshaer, Shereen Saeid; Emara, Ibrahim Ali; Maged, Mohamad; Abdel-Aziz, Amal Kamal |
| 2020 | Tuning mTORC1 activity dictates the response of acute myeloid leukemia to LSD1 inhibition | Abdel-Aziz, Amal Kamal ; Pallavicini, Isabella; Ceccacci, Elena; Meroni, Giuseppe; Saadeldin, Mona Kamal; Varasi, Mario; Minucci, Saverio |
| 2016 | The tyrosine kinase inhibitor, sunitinib malate, induces cognitive impairment in vivo via dysregulating VEGFR signaling, apoptotic and autophagic machineries | Abdel-Aziz, Amal Kamal ; Mantawy, Eman M; Said, Riham Soliman; Helwa, Reham |
